A new study establishes a link between glucagon-like peptide-1 (GLP-1) release from the gut and the cardiac hormone atrial natriuretic peptide, which lowers blood pressure. As GLP-1 receptor agonists are used to control glycemia in patients with type 2 diabetes, this new gut-heart axis suggests a role of these agents in overall cardiovascular homeostasis (pages 567–575).
References
Cataliotti, A., Costello-Boerrigter, L.C., Chen, H.H., Textor, S.C. & Burnett, J.C. Jr. Mayo Clin. Proc. 87, 413–415 (2012).
de Bold, A.J., Borenstein, H.B., Veress, A.T. & Sonnenberg, H. Life Sci. 28, 89–94 (1981).
Newton-Cheh, C. et al. Nat. Genet. 41, 348–353 (2009).
Cannone, V. et al. J. Am. Coll. Cardiol. 58, 629–636 (2011).
Kim, M. et al. Nat. Med. 19, 567–575 (2013).
Wang, B. et al. Diabetes Obes. Metab. published online, http://dx.doi.org/10.1111/dom.12085 (20 March 2013).
Wang, T.J. et al. Circulation 109, 594–600 (2004).
Ingelsson, E. et al. Circulation 116, 984–992 (2007).
Inoue, T., Nonoguchi, H. & Tomit, K. Cardiovasc. Res. 51, 470–480 (2001).
Cannon, W.B. The Wisdom of the Body (W.W. Norton & Company, 1932).
Sengenès, C., Berlan, M., De Glisezinski, I., Lafontan, M. & Galitzky, J. FASEB J. 14, 1345–1351 (2000).
Bordicchia, M. et al. J. Clin. Invest. 122, 1022–1036 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Buglioni, A., Burnett, J. A gut-heart connection in cardiometabolic regulation. Nat Med 19, 534–536 (2013). https://doi.org/10.1038/nm.3196
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3196
- Springer Nature America, Inc.
This article is cited by
-
Alterations in gut microbiota and host transcriptome of patients with coronary artery disease
BMC Microbiology (2023)
-
Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E−/− mice
Microbiome (2017)
-
Corin in Natriuretic Peptide Processing and Hypertension
Current Hypertension Reports (2014)
-
Direct cardiovascular effects of glucagon like peptide-1
Diabetology & Metabolic Syndrome (2013)